Numerous clinical trials are always active (ie, open and enrolling patients) in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults who have or are at risk of developing cancer. The buttons below depict the general research categories being investigated in ECOG-ACRIN clinical trials. To access information within a particular category, click on the relevant button. Upon clicking, the color of the button will change from grey to red, and a table will appear on screen. The table will display the study number, study description, lead investigator(s), accrual goal, and the date the trial was activated (began enrolling patients). Please read the ECOG-ACRIN Disclaimer in its entirety before accessing this information.
To inquire about a particular trial, send us an email using our contact form. Alternatively, send an email to the study chair; click on their hyperlinked name and a new email window will open. To view educational materials, click on the links provided in the Educational Materials column.
Genitourinary Cancer Trials Currently Recruiting Participants
STUDY DESCRIPTION ECOG-ACRIN STUDY CHAIR
EA8134 aka InPACT International Penile Advanced Cancer Trial
Sponsored by The Institute of Cancer Research (UK/EU) on behalf of the International Rare Cancers Initiative in Penile Cancer UK Group, and the National Cancer Institute (US)
Coordinated in the US by the ECOG-ACRIN Cancer Research Group
Curtis A. Pettaway, MD, Chair
(Yu-Hui Chen, MPH, MS)
in the U.S.
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC) Lauren C. Harshman, MD, Chair
David F. McDermott, MD, Co-Chair
(Maneka Puligandla, MS)
766 02/02/2017 EA8143 Resources